Danimer Scientific, Inc. (DNMRQ)
OTCMKTS · Delayed Price · Currency is USD
0.0200
0.00 (0.00%)
Inactive · Last trade price on Jul 25, 2025
Danimer Scientific Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -111.2 | -155.47 | -179.76 | -60.11 | -8.85 | -19.51 |
Depreciation & Amortization | 29.72 | 29.38 | 20.45 | 11.67 | 5.12 | 4.07 |
Other Amortization | 11.73 | 8.99 | 2.1 | 0.48 | 1.66 | 1.51 |
Loss (Gain) From Sale of Assets | 0.64 | 0.25 | - | - | -0.01 | -0.28 |
Asset Writedown & Restructuring Costs | 0.19 | 0.19 | 63.49 | - | - | - |
Stock-Based Compensation | 15.5 | 56.04 | 56.96 | 55.27 | 3.65 | 5.27 |
Provision & Write-off of Bad Debts | 0.65 | -1.42 | 3.12 | 0.52 | - | - |
Other Operating Activities | -10.91 | 1.29 | -8.88 | -41.41 | -8.18 | -1.41 |
Change in Accounts Receivable | -0.5 | 3.17 | -4.91 | -13.47 | -2.31 | 1.44 |
Change in Inventory | -0.28 | 6.48 | -11.17 | -9.8 | -6.6 | -2.99 |
Change in Accounts Payable | 0.79 | -0.64 | -1.57 | 2.05 | 0.99 | 3.64 |
Change in Unearned Revenue | 0.48 | 1 | -0.21 | -2.24 | -2.13 | -0.42 |
Change in Other Net Operating Assets | 0.8 | 3.48 | -1.46 | -5.94 | 2.86 | 7.02 |
Operating Cash Flow | -62.39 | -47.26 | -61.84 | -62.96 | -13.8 | -1.67 |
Capital Expenditures | -9.45 | -27.69 | -164.49 | -185.41 | -38.27 | -36.56 |
Sale of Property, Plant & Equipment | 1.17 | 0.02 | 0.06 | 0.42 | 0.01 | 0.88 |
Cash Acquisitions | - | - | -0.01 | -151.18 | - | - |
Investing Cash Flow | -8.28 | -27.66 | -182.48 | -336.17 | -38.26 | -49.09 |
Long-Term Debt Issued | - | 130 | 24.7 | 240.25 | 4.55 | 69.25 |
Long-Term Debt Repaid | - | -13.03 | -1.5 | -27.16 | -1.94 | -15.22 |
Net Debt Issued (Repaid) | 2.53 | 116.97 | 23.2 | 213.08 | 2.61 | 54.03 |
Issuance of Common Stock | 4.92 | 0.51 | 0.59 | 141.2 | 441.76 | 8.75 |
Repurchase of Common Stock | -0.12 | -0.15 | -0.15 | -1.73 | - | -4.6 |
Other Financing Activities | 7.79 | -33.3 | -1.88 | -46.35 | -21.69 | -4.68 |
Financing Cash Flow | 15.12 | 84.03 | 21.75 | 306.2 | 422.68 | 53.5 |
Net Cash Flow | -55.55 | 9.1 | -222.57 | -92.93 | 370.62 | 2.73 |
Free Cash Flow | -71.84 | -74.95 | -226.32 | -248.37 | -52.07 | -38.23 |
Free Cash Flow Margin | -191.95% | -160.55% | -425.27% | -422.77% | -110.00% | -118.21% |
Free Cash Flow Per Share | -26.00 | -29.39 | -89.55 | -106.74 | -70.43 | -60.36 |
Cash Interest Paid | 25.73 | 23.17 | 0.4 | 0.51 | 1.45 | 1.96 |
Cash Income Tax Paid | - | - | - | - | 0.02 | - |
Levered Free Cash Flow | -26.48 | -25.6 | -191.72 | -191.52 | -48.26 | -21.03 |
Unlevered Free Cash Flow | -15.68 | -16.06 | -192.75 | -191.52 | -48.61 | -20.58 |